QUANTITATIVE RISK-BENEFIT ANALYSIS IN REGULATORY DECISION-MAKING - A FUNDAMENTAL PROBLEM AND AN ALTERNATIVE PROPOSAL

被引：6
|
作者：
BOGEN, KT
机构：
来源：
JOURNAL OF HEALTH POLITICS POLICY AND LAW | 1983年 / 8卷 / 01期
关键词：
D O I：
10.1215/03616878-8-1-120
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：120 / 143
页数：24
相关论文
共 50 条
  • [1] RISK-BENEFIT ANALYSIS IN REGULATORY DECISION-MAKING
    HIGHLAND, JH
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1979, 329 (OCT) : 263 - 266
  • [2] ROLE OF REGULATORY AGENCIES IN RISK-BENEFIT DECISION-MAKING
    COOPER, RM
    [J]. FOOD AND DRUG LAW JOURNAL, 1978, 33 (12): : 755 - 773
  • [3] A Benefit-Risk Analysis Approach to Capture Regulatory Decision-Making: Multiple Myeloma
    Raju, G. K.
    Gurumurthi, Karthik
    Domike, Reuben
    Kazandjian, Dickran
    Landgren, Ola
    Blumenthal, Gideon M.
    Farrell, Ann
    Pazdur, Richard
    Woodcock, Janet
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (01) : 67 - 76
  • [4] Quantitative risk-benefit analysis of natalizumab
    Thompson, J. P.
    Noyes, K.
    Dorsey, E. R.
    Schwid, S. R.
    Holloway, R. G.
    [J]. NEUROLOGY, 2008, 71 (05) : 357 - 364
  • [5] REGULATORY ASPECTS OF FOOD ADDITIVE RISK-BENEFIT PROBLEM
    ROBERTS, HR
    [J]. FOOD TECHNOLOGY, 1978, 32 (08) : 59 - 61
  • [6] MAKING RISK-BENEFIT DECISION - A RATIONAL APPROACH TO SAFETY
    不详
    [J]. MODERN PLASTICS, 1978, 55 (03): : 18 - 18
  • [7] Benefit-Risk Analysis for Decision-Making: An Approach
    Raju, G. K.
    Gurumurthi, K.
    Domike, R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (06) : 654 - 671
  • [8] Decision-making when data and inferences are not conclusive: Risk-benefit and acceptable regret approach
    Hozo, Iztok
    Schell, Michael J.
    Djulbegovic, Benjamin
    [J]. SEMINARS IN HEMATOLOGY, 2008, 45 (03) : 150 - 159
  • [9] Risk-benefit physician decision-making for cardiac catheterization: Insights from the race car study
    Kreatsoulas, C.
    Sloane, D.
    Velianou, J. L.
    Anand, S. S.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 : 235C - 235C
  • [10] QUANTITATIVE RISK-BENEFIT ANALYSIS OF NATALIZUMAB Reply
    Holloway, R. G.
    Thompson, J. P.
    Noyes, K.
    Dorsey, E. R.
    Schwid, S. R.
    [J]. NEUROLOGY, 2009, 72 (20) : 1791 - 1792
12345